The results showed a strong trend toward decreasing growth factor signaling in both cell lines, with PC3 tumors exhibiting more significant responses ( Fig. 2 F ).
← all excerpts
Computational modeling identifies multitargeted kinase inhibitors as effective therapies for metastatic, castration-resistant prostate cancer.
1
—
—